Analysis of CDCP1 mRNA in a CRC cohort of 101 patients indicated that elevated levels correlate significantly with advanced stage, node metastasis, and diminished recurrence-free and overall survival [26]. This evidence concerns the gene CDCP1 and colorectal carcinoma.